Article Text

Download PDFPDF
Randomised controlled trial
Initiating antiretroviral therapy in HIV-infected patients with >500 CD4 cells/µL provides more benefit than delaying treatment

Statistics from Altmetric.com

Footnotes

  • Contributors GWR wrote the manuscript. AA contributed to the analysis, reviewed and approved the manuscript.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.